Особенности листовидных опухолей
Данила Александрович Денчик, И К Воротников, Л. Н. Любченко et al. · CyberLeninK (CyberLeninka) · 2010
Brodies tumors are comparatively rare in oncological care and difficult-to-diagnose masses with an unpredictable course, predilection for recurrences, and a high probability of malignization. These tumors have a two-component structure with the predominant development of a connective tissue component that is absolute in sarcomas and, in a group of fibroepithelial tumors, combines with the parallel development of epithelial tissue. The etiology of Brodies tumor is unclear, so is its pathogenesis. Molecular genetic studies have shown that the carriers of germ line missence-mutation R1699W in the BRCA1 gene have an increased risk of developing malignant Brodies tumor, but allele losses at the D22S264 locus of the TP5 gene determine the progression of the disease. Deletion of the short-arm of chromosome 1 (1p) and allelic imbalance are associated with the more aggressive course and recurrences of Brodies tumor. A complex clinicomorphological and molecular genetic study will help answer some questions concerning the diagnosis and treatment of Brodies tumors.
Cited by 0 works.